Charles River Laboratories | CRL - Selling And Administration Expenses


Charles River Laboratories reported $159.42M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agilent USD 465M 11M Mar/2026
Align Technology USD 462.67M 2.67M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Cardinal Health USD 1.51B 6M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cigna USD 3.47B 152M Jun/2026
Concord Medical Services Hldg CNY 124.78M 15.58M Dec/2025
Danaher USD 2.07B 212M Jun/2026
Dentsply International USD 351M 32M Mar/2026
Elevance Health USD 10.91B 309M Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 273M 1000K Jun/2026
Incyte USD 351.73M 23.64M Jun/2026
Intrexon USD 10.31M 41K Jun/2024
IQVIA Holdings USD 574M 72M Jun/2026
Laboratory Of America USD 577.2M 26.2M Jun/2026
Lakefront Biotherapeutics EUR 35.5M 8.91M Mar/2026
McKesson USD 1.8B 234M Mar/2026
Merck EUR 1.52B 80M Mar/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Novartis USD 3.24B 101M Jun/2026
Pfizer USD 3.41B 496M Jun/2026
Quest Diagnostics USD 529M 25M Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
United Therapeutics USD 156.6M 34M Mar/2026
UnitedHealth USD 15.22B 1.44B Sep/2025
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 405M 11M Jun/2026
West Pharmaceutical Services USD 117.6M 18.1M Jun/2026